Investigating the immune response to combination therapies in pancreatic cancer.

研究胰腺癌联合疗法的免疫反应。

• 批准号: 2885547
• 金额: --
• 依托单位: University of Oxford
• 依托单位国家: 英国
• 项目类别: Studentship
• 财政年份: 2023
• 资助国家: 英国
• 起止时间: 2023 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=studentship-2885547
• 关键词: Investigating; immune; response; combination; therapies

The research project focuses on developing new therapies for pancreatic cancer and is therefore focused on highest priority healthcare challenge. Uniquely, as the project is a combination of research and surgery it is expanding the frontiers of physical intervention. Also, through understanding early disease biology the project fits the EPSRC aspiration of optimising disease prediction, prevention, diagnosis and intervention.

该研究项目的重点是开发胰腺癌的新疗法，因此专注于最优先的医疗保健挑战。独特的是，由于该项目是研究和手术的结合，它正在扩大物理干预的前沿。此外，通过了解早期疾病生物学，该项目符合EPSRC优化疾病预测，预防，诊断和干预的愿望。